Status:
COMPLETED
Vital Signs Camera Study
Lead Sponsor:
Philips Clinical & Medical Affairs Global
Conditions:
Respiration Rate
Heart Rate
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is a single center, prospective clinical investigation which is balanced for gender, age, Body Mass Index (BMI) and skin color. Simultaneous measurements of PR and RR on study participants ...
Eligibility Criteria
Inclusion
- Persons with ASA I or II classification
- Adult population (age \>18 years old)
- BMI ≥ 18 - ≤ 40 kg/m2
- Able to intensively exercise for 10 minutes
- Persons willing to give informed consent
- Willingness to have vital signs measured by a medical mobile application
- Willingness to follow study protocol (e.g., put on sunglasses, facial make-up, medical face-mask and sitting still up to 2 minutes)
Exclusion
- Vulnerable populations (e.g., age \<18 years old, not able to consent by themselves, or immunecompromised or pregnant women)
- Cardiac arrhythmias (e.g., Atrial Fibrillation, Supraventricular Tachycardia, Ventricular arrhythmia, regular ectopic beats)
- Persons present signs of infection
- Participant has known allergic reactions to make-up and/or make-up remover
- Persons with positive COVID 19 test in last 14 days
- Participant who exhibit irregular or excessive movement such as tremors, tics, shaking and/or shivering
- Participant is Philips employee or their family members residing with this Philips employee.
Key Trial Info
Start Date :
February 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2024
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT06140433
Start Date
February 2 2024
End Date
March 15 2024
Last Update
July 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Philips
Eindhoven, North Brabant, Netherlands, 5656AE